Barclays Thinks Ionis Headed Toward a $106 Target This Year
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
This comparison outlines 2024 tax treatment differences between dividends from ETFs and mutual funds for informed decisions.
24,763 articlesBarclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
Walmart’s John Furner rose from a garden center associate to CEO of Walmart U.S., guiding the retailer through a tech...
Jamie Dimon argues that insecurity is the real career killer for CEOs as they move from specialists to generalists. T...
As collections on federal student loans restart, Gen Z is bearing the cost with rising delinquencies and falling cred...
Three quantum hardware players—IonQ, D-Wave, and Rigetti—are confronting a tough market reality. This article breaks ...
AMH reports solid 2025 results as it navigates an overbuilt rental market, with revenue gains driven by disciplined a...
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...
Trading activity in the largest non-stablecoin crypto assets cooled to two-year lows as investors sit on the sideline...
NVIDIA shattered expectations with a historic earnings beat, but its stock moved lower as traders reassessed forward ...
Biotech stocks can swing wildly on quarterly results and guidance. This article unpacks why genedx stock plummeting t...
Roughly 1 in 10 Medicare Advantage enrollees will lose their current plan for 2026 as insurers retreat from markets. ...
IonQ is making waves as its stock jumps amid a supportive but uncertain market for quantum-tech plays. This article b...